0QF:FRA
Moderna Inc
€ 175.36
arrow_upward
+1.08%(+1.88) Siku 1
8 Okt, 15:11:49 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 0QF...
Fungua
€ 173.02
Juu
€ 175.36
Chini
€ 173.00
Mtaji wa soko
78.44B
Wastani wa kiasi cha mauzo
elfu 1.60
Kiasi cha mauzo ya hisa
elfu 1.10
Juu kwa wiki 52
€ 186.34
Chini kwa wiki 52
€ 19.26
Idadi ya wafanyakazi
elfu 5
Fungua
€ 173.02
Juu
€ 175.36
Chini
€ 173.00
Mtaji wa soko
78.44B
Wastani wa kiasi cha mauzo
elfu 1.60
Kiasi cha mauzo ya hisa
elfu 1.10
Juu kwa wiki 52
€ 186.34
Chini kwa wiki 52
€ 19.26
Idadi ya wafanyakazi
elfu 5
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
saa 1 iliyopita
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
The Motley Fool
·
saa 10 zilizopita
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
GuruFocus
·
saa 16 zilizopita
Moderna (MRNA) Shares Rise 4.8% Despite Broad Market Weakness on October 7, 2026
Investopedia
·
saa 17 zilizopita
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets
Wasifu
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Kuhusu Moderna Inc
Afisa Mkuu Mtendaji (CEO)Stéphane Bancel
Wafanyakazielfu 4.7
LilianzishwaSep 2010
Makao makuu-
Sekta-
Tovutimodernatx.com